Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 4/20 | 0.51 |
| ▸ | CTSK | P43235 | 4/20 | 0.51 |
| ▸ | CTSL | P07711 | 1/20 | 0.51 |
| ▸ | CTSB | P07858 | 1/20 | 0.51 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.51 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.51 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.51 |
| ▸ | AKT1 | P31749 | 1/20 | 0.48 |
| ▸ | REN | P00797 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.46 |
| ▸ | CCKBR | P32239 | 1/20 | 0.45 |
| ▸ | NPY1R | P25929 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5966558 | 0.93 | CTSK (0.51) | CTSSCTSKCTSLCTSBAKT1 | |
| SCHEMBL5966599 | 0.92 | CTSS (0.50) | CTSSCTSKCTSLCTSBPSMB8 | |
| SCHEMBL5966565 | 0.91 | CTSS (0.49) | CTSSCTSKCTSLCTSBAKT1 | |
| SCHEMBL8120447 | 0.87 | CA2 (0.52) | CTSSCTSKPSMB8PSMB9PSMB5 | |
| SCHEMBL8112857 | 0.87 | CA2 (0.52) | CTSSCTSKCA1CA2NPY1R | |
| SCHEMBL5966493 | 0.87 | CTSS (0.52) | CTSSCTSKCTSLCTSBPSMB8 | |
| SCHEMBL14685023 | 0.87 | CXCR3 (0.47) | CTSSCTSKCTSLCTSBAKT1 | |
| SCHEMBL8120925 | 0.86 | CA2 (0.51) | CTSSCTSKCTSLPSMB8PSMB9 | |
| SCHEMBL5966537 | 0.86 | CTSS (0.53) | CTSSCTSKCTSLCTSBPSMB8 | |
| SCHEMBL8114815 | 0.86 | CA2 (0.53) | CTSSCTSKPSMB8PSMB9PSMB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | THE PROCTER & GAMBLE COMPANY | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | MC3R, MC4R, MC1R | CTSS 2475/4885CTSK 3132/4885CTSL 3363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.